![The CDC and WHO have identified key groups who face an increased risk for TB infection and disease progression.](/%5E%5Ecdi={43513A8D-0012-473A-A5A1-570018B04076}%5Ehash=/-/media/project/qiagen/qiagen-home/content-worlds/tb-management/tb-testing/s_1145_6_oft_generic_gi1213309844.jpg)
Discover – TB management
Understanding TB
Latest insights – webinars, stories and more
It’s time to test and treat TB
TB disease is preventable and curable. If LTBI is recognized early, effective preventive treatment can be provided by your doctor. If TB is active, a treatment of multiple drugs is required for a minimum of 6 months that will usually cure the disease and lead to a full recovery.
The World Health Organization (WHO) acknowledges that to fight TB effectively, the accurate identification and treatment of LTBI as well as active TB disease are vital (1).
International efforts have succeeded in slowing the COVID-19 epidemic – but responding to COVID-19 has also forced disruption of existing TB control programs around the globe. It’s time for immediate action to stem the potential flood of TB – including a massive catch-up effort to actively diagnose, trace, treat and prevent the disease.
Together we can defeat TB
Featured QFT-Plus resources
References:
1. World Health Organization. (2020) WHO consolidated guidelines on tuberculosis: tuberculosis preventive treatment.
2. QuantiFERON-TB Gold Plus (QFT-Plus) ELISA Package Insert. Current QFT-Plus package inserts are available at www.QuantiFERON.com
3. Diel, R., Loddenkemper, R., and Nienhaus, A. (2010) Chest 137, 952.
4. Harada, N. et al. (2008) J. Infect. 56, 348.
5. Turner, J. et al. (1996) Immunology 87, 339.
6. Brookes, R.H. et al. (2003) Eur. J. Immunol. 33, 3293.
7. Stenger, S. et al. (1998) Science 282, 121.
*QuantiFERON-TB Gold Plus Blood Collection Tubes by QIAGEN and LIAISON Analyzer by DiaSorin.
QFT-Plus is an in vitro diagnostic aid for the detection of Mycobacterium tuberculosis infection. QFT-Plus is an indirect test for M. tuberculosis infection (including disease) and is intended for use in conjunction with risk assessment, radiography, and other medical and diagnostic evaluations. QFT-Plus Package Inserts, available in multiple languages, as well as up-to-date licensing information and product-specific disclaimers can be found at www.QuantiFERON.com.